NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹275 Cr | ₹236 Cr | ₹264 Cr | ₹162 Cr | ₹146 Cr |
What is the latest Trade Payables ratio of NATCO PHARMA ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹275 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹264 Cr |
| Mar2022 | ₹162 Cr |
| Mar2021 | ₹146 Cr |
How is Trade Payables of NATCO PHARMA Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹275 Cr | 16.73 | |
| Mar2024 | ₹236 Cr | -10.73 | |
| Mar2023 | ₹264 Cr | 63.04 | |
| Mar2022 | ₹162 Cr | 10.67 | |
| Mar2021 | ₹146 Cr | - | |
Compare Trade Payables of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹19,565.8 Cr | -0.6% | 14.1% | 29.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.6% |
14.1% |
29.2% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses